glp 1 agonists and inflammation The anti-inflammatory feature of glucagon-like peptide-1 its based diabetes drugs—Therapeutic potential exploration in lung injury GLP-1 Drugs: For Multiple Chronic

Potential advantages Generally simpler anatomy than gastric bypass No intestinal rerouting Strong option for many first-time bariatric surgery patients Can be a good fit for patients who want a restrictive/metabolic procedure Usually avoids the malabsorption component of bypass Important considerations May worsen or trigger acid reflux in some patients May not be the best option for severe GERD or Barretts esophagus Requires lifelong attention to portion size, protein, vitamins, and habits Some patients may need revision later if reflux or weight regain occurs Gastric Bypass Also called Roux-en-Y gastric bypass Gastric bypass creates a small stomach pouch and reroutes part of the small intestine

Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among us adults with overweight or obesity

Blood in stool : Either bright red blood or black, tarry stools, which may indicate gastrointestinal bleeding

liver or kidney problems

Another promising direction involves dissolving microneedles, which completely degrade upon administration, eliminating the need for disposal and improving patient compliance